Stoll P, Schwer CI, Goebel U, Buerkle H, Hoetzel A, Schmidt R. Hepatic steatosis prevents heme oxygenase-1 induction by isoflurane in the rat liver. World J Gastroenterol 2011; 17(37): 4184-4190 [PMID: 22072849 DOI: 10.3748/wjg.v17.i37.4184]
Corresponding Author of This Article
Rene Schmidt, MD, DESA, Department of Anesthesiology and Critical Care Medicine, Freiburg University Medical Center, Hugstetter Strasse 55, D-79106 Freiburg, Germany. rene.schmidt@uniklinik-freiburg.de
Article-Type of This Article
Original Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Stoll P, Schwer CI, Goebel U, Buerkle H, Hoetzel A, Schmidt R. Hepatic steatosis prevents heme oxygenase-1 induction by isoflurane in the rat liver. World J Gastroenterol 2011; 17(37): 4184-4190 [PMID: 22072849 DOI: 10.3748/wjg.v17.i37.4184]
World J Gastroenterol. Oct 7, 2011; 17(37): 4184-4190 Published online Oct 7, 2011. doi: 10.3748/wjg.v17.i37.4184
Hepatic steatosis prevents heme oxygenase-1 induction by isoflurane in the rat liver
Patrick Stoll, Christian I Schwer, Ulrich Goebel, Hartmut Buerkle, Alexander Hoetzel, Rene Schmidt
Patrick Stoll, Christian I Schwer, Ulrich Goebel, Hartmut Buerkle, Alexander Hoetzel, Rene Schmidt, Department of Anesthesiology and Critical Care Medicine, Freiburg University Medical Center, D-79106 Freiburg, Germany
Author contributions: Stoll P performed all animal experiments and most of the molecular analyzes and wrote the first draft of the manuscript; Schwer CI participated in the research; Goebel U participated in data analysis; Buerkle H wrote the paper; Hoetzel A participated in research design and data analysis; Schmidt R designed the study and wrote the paper.
Supported by Departmental funding
Correspondence to: Rene Schmidt, MD, DESA, Department of Anesthesiology and Critical Care Medicine, Freiburg University Medical Center, Hugstetter Strasse 55, D-79106 Freiburg, Germany. rene.schmidt@uniklinik-freiburg.de
Telephone: +49-761-27023060 Fax: +49-761-27023960
Received: December 30, 2010 Revised: April 7, 2011 Accepted: April 14, 2011 Published online: October 7, 2011
Abstract
AIM: To characterize the inductive effects of isoflurane (ISO) on hepatic heme oxygenase-1 (HO-1) in an animal model of hepatic steatosis.
METHODS: Lean (LEAN) and obese (FAT) Zucker rats were randomized into 4 groups: 1: LEAN + pentobarbital sodium (PEN); 2: LEAN + ISO; 3: FAT + PEN; 4: FAT + ISO. The animals were mechanically ventilated for 6 h. In vitro analyses of liver tissue included determination of HO-1 mRNA and protein expression as well as measurement of HO enzyme activity and immunohistochemical analyses.
RESULTS: Compared to PEN treatment, ISO administration profoundly induced hepatic HO-1 mRNA and protein expression and significantly increased HO enzyme activity in lean Zucker rats. In contrast, no difference in HO-1 gene expression was observed after ISO or PEN anesthesia in obese Zucker rats.
CONCLUSION: The present study demonstrates that ISO is an inducer of hepatic HO-1 gene expression in non-steatotic organs but failed to upregulate HO-1 in steatotic livers.
